Retatrutide Research FAQ — Purity, Legality & Sourcing in the UAE (2026)

What Is Retatrutide?

Retatrutide is a research peptide studied in the pharmacological literature as a triple agonist — engaging the GLP-1, GIP and glucagon receptors. It has a molecular weight of approximately 4731 Da and has been evaluated in peer-reviewed research, including a Phase 2 trial published in the New England Journal of Medicine (NEJM) in 2023. For mechanism detail, see our mechanism of action research article; for trial context, see our clinical trial literature review.

Sourcing and Purity Questions

How does REVIVE verify retatrutide purity?

Every batch is independently tested by HPLC (high-performance liquid chromatography), the standard analytical method for peptide purity verification in research supply chains. REVIVE's retatrutide is verified at ≥99.0% purity, and each vial ships with a certificate of analysis (COA) documenting batch number, manufacture date and the HPLC purity result.

What comes in the box?

A 10 mg lyophilised (freeze-dried) powder vial, sealed and desiccated for stability, accompanied by the COA and clear Research Use Only labelling.

Can I request the raw COA data before ordering?

Yes — research buyers and institutional labs can request batch-specific COA documentation. This is standard practice for any laboratory sourcing decision and REVIVE supports it as part of transparent research supply.

Legal and Regulatory Questions

Is it legal to buy research peptides like retatrutide in the UAE?

REVIVE LAB UAE operates as a B2B supplier of laboratory research reference materials to research institutions, laboratories and qualified research buyers across the UAE. Every product is sold strictly for research use and labelled accordingly. Buyers are responsible for ensuring their own institutional and regulatory compliance under applicable UAE law — this FAQ is not legal advice, and research buyers with specific compliance questions should consult their institution's regulatory affairs office.

What is retatrutide's current regulatory status?

Retatrutide is a research compound under academic and pharmaceutical-industry study; it does not carry general pharmaceutical marketing approval as a standalone consumer product. REVIVE's vial is supplied and labelled strictly as a laboratory research reference material, consistent with that status — not as an approved drug product.

Does REVIVE ship internationally or only within the UAE?

REVIVE LAB UAE's cold-chain logistics network is built around UAE-wide delivery — Dubai, Abu Dhabi, Sharjah and the Northern Emirates. See the product page for current shipping coverage.

Storage and Handling Questions

How should the vial be stored?

Lyophilised retatrutide should be kept desiccated at −20°C until laboratory use. This is general storage guidance for maintaining compound stability, not usage instructions.

How is the powder reconstituted for laboratory work?

Standard laboratory practice is to reconstitute the lyophilised powder with bacteriostatic water — typically 3–5 mL for a 10 mg vial — to bring it into solution for research handling. This describes lab preparation only; REVIVE does not provide dosing or administration guidance.

Does REVIVE answer dosing questions?

No. REVIVE does not provide dosing, administration frequency, or any usage instructions for retatrutide or any other product. All compounds sold by REVIVE LAB UAE are Research Use Only, and researchers should follow their own institution's protocols and applicable regulatory guidance for any laboratory work.

Retatrutide Vial Reference Table